Advertisement

Advertisement

FBLG Stock Latest News

Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD)

TipRanks NewswireWhy the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD)

FibroBiologics Shareholders Approve Potential Warrant-Driven Share Issuance

PremiumCompany Announcements

FibroBiologics Shareholders Approve Potential Warrant-Driven Share Issuance

10d ago

FibroBiologics Announces Insider Private Placement Financing

PremiumCompany Announcements

FibroBiologics Announces Insider Private Placement Financing

13d ago

FibroBiologics announces USPTO issued patent on use of fibroblasts

PremiumThe Fly

FibroBiologics announces USPTO issued patent on use of fibroblasts

25d ago

FibroBiologics announces USPTO issued patent for Fibroblast Conditioned Media

PremiumThe Fly

FibroBiologics announces USPTO issued patent for Fibroblast Conditioned Media

27d ago

FibroBiologics Adds Leigh Steinberg to Board for Growth

PremiumCompany AnnouncementsFibroBiologics Adds Leigh Steinberg to Board for Growth

1M ago

FibroBiologics says Australian patent accepted for Cannabidiol Adjuvant Therapy

The Fly

FibroBiologics says Australian patent accepted for Cannabidiol Adjuvant Therapy

1M ago

FibroBiologics announces laboratory findings in joint cartilage repair

The Fly

FibroBiologics announces laboratory findings in joint cartilage repair

1M ago

FibroBiologics awarded new patent from USPTO

PremiumThe Fly

FibroBiologics awarded new patent from USPTO

2M ago

FibroBiologics announces EPO granted patent for gene cartilage therapy

PremiumThe Fly

FibroBiologics announces EPO granted patent for gene cartilage therapy

2M ago

FibroBiologics price target lowered to $6 from $8 at H.C. Wainwright

PremiumThe Fly

FibroBiologics price target lowered to $6 from $8 at H.C. Wainwright

2M ago

FibroBiologics Faces Material Clinical Trial and Regulatory Risks That Threaten Commercialization Timeline and Long-Term Outlook

PremiumCompany Announcements

FibroBiologics Faces Material Clinical Trial and Regulatory Risks That Threaten Commercialization Timeline and Long-Term Outlook

2M ago

FibroBiologics Faces Nasdaq Delisting, Appeals Planned

PremiumCompany AnnouncementsFibroBiologics Faces Nasdaq Delisting, Appeals Planned

2M ago

FibroBiologics files to sell up to 12.53M shares of common stock

The Fly

FibroBiologics files to sell up to 12.53M shares of common stock

3M ago

FibroBiologics Appoints NASA Scientist Kate Rubins to Board

Company Announcements

FibroBiologics Appoints NASA Scientist Kate Rubins to Board

3M ago

FibroBiologics appoints Rubins to its Board of Directors

PremiumThe Fly

FibroBiologics appoints Rubins to its Board of Directors

3M ago

FibroBiologics completes manufacturing of third batch of CYWC628

PremiumThe Fly

FibroBiologics completes manufacturing of third batch of CYWC628

3M ago

FibroBiologics Secures New Private Placement Financing

PremiumCompany Announcements

FibroBiologics Secures New Private Placement Financing

3M ago

FibroBiologics announces $9M private placement priced at-the-market

PremiumThe Fly

FibroBiologics announces $9M private placement priced at-the-market

3M ago

FibroBiologics Shareholders Approve New 2026 Equity Plan

PremiumCompany AnnouncementsFibroBiologics Shareholders Approve New 2026 Equity Plan

3M ago

FibroBiologics receives notice of allowance for U.S. patent

The Fly

FibroBiologics receives notice of allowance for U.S. patent

3M ago

FibroBiologics doses first patients in CYWC628 clinical trial

The Fly

FibroBiologics doses first patients in CYWC628 clinical trial

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >